Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.72097845 |
2 | positive T cell selection (GO:0043368) | 5.25041137 |
3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.23713312 |
4 | activated T cell proliferation (GO:0050798) | 5.23638855 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.03260279 |
6 | negative regulation of cell killing (GO:0031342) | 5.03260279 |
7 | V(D)J recombination (GO:0033151) | 5.01539260 |
8 | negative T cell selection (GO:0043383) | 4.93514464 |
9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.89313318 |
10 | T cell selection (GO:0045058) | 4.58396150 |
11 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.54243202 |
12 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.09865573 |
13 | positive thymic T cell selection (GO:0045059) | 4.06499176 |
14 | interferon-gamma production (GO:0032609) | 3.96257964 |
15 | detection of molecule of bacterial origin (GO:0032490) | 3.95429897 |
16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.95222462 |
17 | negative thymic T cell selection (GO:0045060) | 3.90197303 |
18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.85350337 |
19 | detection of other organism (GO:0098543) | 3.79100737 |
20 | response to peptidoglycan (GO:0032494) | 3.78292835 |
21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.76256557 |
22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.70497447 |
23 | neutrophil activation involved in immune response (GO:0002283) | 3.60145972 |
24 | thymic T cell selection (GO:0045061) | 3.51315609 |
25 | leukocyte aggregation (GO:0070486) | 3.48320219 |
26 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.47376001 |
27 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.47376001 |
28 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.47376001 |
29 | response to muramyl dipeptide (GO:0032495) | 3.45485593 |
30 | regulation of T cell tolerance induction (GO:0002664) | 3.45403466 |
31 | detection of external biotic stimulus (GO:0098581) | 3.43332613 |
32 | microglial cell activation (GO:0001774) | 3.43069818 |
33 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.39880254 |
34 | T cell receptor signaling pathway (GO:0050852) | 3.38812158 |
35 | response to host immune response (GO:0052572) | 3.38575933 |
36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.38575933 |
37 | modulation by virus of host process (GO:0019054) | 3.37334733 |
38 | detection of bacterium (GO:0016045) | 3.35394353 |
39 | modulation by symbiont of host cellular process (GO:0044068) | 3.32694607 |
40 | negative regulation of T cell mediated immunity (GO:0002710) | 3.31950320 |
41 | mitotic sister chromatid cohesion (GO:0007064) | 3.31717308 |
42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.31171988 |
43 | modulation by symbiont of host defense response (GO:0052031) | 3.31171988 |
44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.31171988 |
45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.31171988 |
46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.31171988 |
47 | modulation by symbiont of host immune response (GO:0052553) | 3.31171988 |
48 | response to host (GO:0075136) | 3.28893772 |
49 | response to host defenses (GO:0052200) | 3.28893772 |
50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.28893772 |
51 | negative regulation of interleukin-12 production (GO:0032695) | 3.28307857 |
52 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.25261035 |
53 | regulation of thymocyte apoptotic process (GO:0070243) | 3.21374955 |
54 | positive regulation of B cell differentiation (GO:0045579) | 3.20938531 |
55 | histone H3-K4 trimethylation (GO:0080182) | 3.20674311 |
56 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.20162654 |
57 | alpha-beta T cell differentiation (GO:0046632) | 3.18995736 |
58 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.18550565 |
59 | positive regulation of interleukin-2 production (GO:0032743) | 3.18054203 |
60 | alpha-beta T cell activation (GO:0046631) | 3.17537882 |
61 | regulation of B cell differentiation (GO:0045577) | 3.16505175 |
62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.15063787 |
63 | B cell receptor signaling pathway (GO:0050853) | 3.13630031 |
64 | T cell homeostasis (GO:0043029) | 3.12883659 |
65 | mast cell activation (GO:0045576) | 3.10546267 |
66 | detection of biotic stimulus (GO:0009595) | 3.07486751 |
67 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.06616940 |
68 | tolerance induction (GO:0002507) | 3.06152923 |
69 | respiratory burst (GO:0045730) | 3.05943768 |
70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.05903008 |
71 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.03130943 |
72 | neutrophil mediated immunity (GO:0002446) | 3.02889872 |
73 | T cell costimulation (GO:0031295) | 3.01917594 |
74 | pre-miRNA processing (GO:0031054) | 3.00907093 |
75 | T cell differentiation (GO:0030217) | 2.95214499 |
76 | lymphocyte costimulation (GO:0031294) | 2.94767693 |
77 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.90510883 |
78 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.90510883 |
79 | macrophage activation (GO:0042116) | 2.88656026 |
80 | positive regulation of mast cell activation (GO:0033005) | 2.86898129 |
81 | T cell proliferation (GO:0042098) | 2.86290869 |
82 | lymphocyte homeostasis (GO:0002260) | 2.85421641 |
83 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.85346499 |
84 | mast cell activation involved in immune response (GO:0002279) | 2.83516835 |
85 | mast cell degranulation (GO:0043303) | 2.83516835 |
86 | positive regulation of tolerance induction (GO:0002645) | 2.82419706 |
87 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.82110383 |
88 | response to interleukin-15 (GO:0070672) | 2.81642789 |
89 | positive regulation of histone deacetylation (GO:0031065) | 2.79418677 |
90 | regulation of leukocyte degranulation (GO:0043300) | 2.78173722 |
91 | regulation of tolerance induction (GO:0002643) | 2.77657100 |
92 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.77588786 |
93 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.77588786 |
94 | nuclear pore organization (GO:0006999) | 2.77363279 |
95 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76974385 |
96 | regulation of mast cell degranulation (GO:0043304) | 2.76614536 |
97 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.74713672 |
98 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.74713672 |
99 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74695702 |
100 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.73445301 |
101 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72935160 |
102 | B cell homeostasis (GO:0001782) | 2.70646256 |
103 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.69612367 |
104 | germinal center formation (GO:0002467) | 2.69131554 |
105 | positive regulation of mRNA catabolic process (GO:0061014) | 2.68877094 |
106 | hypotonic response (GO:0006971) | 2.68065371 |
107 | negative regulation of histone methylation (GO:0031061) | 2.66976618 |
108 | histone lysine demethylation (GO:0070076) | 2.65282853 |
109 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.63831441 |
110 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.63522894 |
111 | cellular extravasation (GO:0045123) | 2.62534740 |
112 | myeloid leukocyte mediated immunity (GO:0002444) | 2.61480588 |
113 | histone H3-K4 methylation (GO:0051568) | 2.60240362 |
114 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.57587739 |
115 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.57164973 |
116 | regulation of histone H3-K9 methylation (GO:0051570) | 2.56799204 |
117 | nuclear pore complex assembly (GO:0051292) | 2.56715714 |
118 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.56259618 |
119 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.56158272 |
120 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.55543340 |
121 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.54900402 |
122 | histone demethylation (GO:0016577) | 2.54484108 |
123 | positive regulation of granulocyte differentiation (GO:0030854) | 2.54137141 |
124 | myeloid cell activation involved in immune response (GO:0002275) | 2.53588762 |
125 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.53415549 |
126 | neutrophil activation (GO:0042119) | 2.53400131 |
127 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.53010956 |
128 | mononuclear cell proliferation (GO:0032943) | 2.52008363 |
129 | macrophage activation involved in immune response (GO:0002281) | 2.51985538 |
130 | histone H3-K9 demethylation (GO:0033169) | 2.51619831 |
131 | NLS-bearing protein import into nucleus (GO:0006607) | 2.50054745 |
132 | lymphocyte proliferation (GO:0046651) | 2.49269869 |
133 | hepatocyte apoptotic process (GO:0097284) | 2.48798348 |
134 | negative regulation of DNA repair (GO:0045738) | 2.47034858 |
135 | negative regulation of B cell proliferation (GO:0030889) | 2.46808293 |
136 | genitalia morphogenesis (GO:0035112) | 2.45758624 |
137 | regulation of mRNA catabolic process (GO:0061013) | 2.45628540 |
138 | regulation of interleukin-2 production (GO:0032663) | 2.45465468 |
139 | histone H3-K36 demethylation (GO:0070544) | 2.45429735 |
140 | regulation of macrophage cytokine production (GO:0010935) | 2.44993292 |
141 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.44533838 |
142 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.44533838 |
143 | pore complex assembly (GO:0046931) | 2.43969779 |
144 | regulation of mast cell activation (GO:0033003) | 2.43897292 |
145 | granulocyte activation (GO:0036230) | 2.43613375 |
146 | B cell proliferation (GO:0042100) | 2.43598685 |
147 | regulation of RNA export from nucleus (GO:0046831) | 2.43199276 |
148 | megakaryocyte development (GO:0035855) | 2.43097106 |
149 | cellular response to interleukin-15 (GO:0071350) | 2.42524542 |
150 | negative regulation of T cell apoptotic process (GO:0070233) | 2.41252093 |
151 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.40425221 |
152 | Peyers patch development (GO:0048541) | 2.40425221 |
153 | T cell migration (GO:0072678) | 2.39158769 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.70789880 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.79823627 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.62309870 |
4 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.94516702 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 3.31531409 |
6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.21470903 |
7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.19193068 |
8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.14479173 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.12515484 |
10 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.05455613 |
11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.05449301 |
12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.95994787 |
13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94032806 |
14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.92450797 |
15 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.92414744 |
16 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83334883 |
17 | MYB_26560356_Chip-Seq_TH2_Human | 2.76073417 |
18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.67144149 |
19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61116271 |
20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.57117680 |
21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54898284 |
22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.54884647 |
23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48231338 |
24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.31425880 |
25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.27502897 |
26 | MYB_26560356_Chip-Seq_TH1_Human | 2.24513412 |
27 | * MAF_26560356_Chip-Seq_TH1_Human | 2.23290363 |
28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.20632464 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18065131 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06203346 |
31 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.01080144 |
32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00873812 |
33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.98706123 |
34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.93895509 |
35 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.92377374 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.89598244 |
37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.88204861 |
38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86924433 |
39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84406826 |
40 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.82585860 |
41 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.82585860 |
42 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.82585860 |
43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80089706 |
44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70628849 |
45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67141627 |
46 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.59393931 |
47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59246699 |
48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55345658 |
49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47922011 |
50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46251960 |
51 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40763723 |
52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39590737 |
53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38025898 |
54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37166069 |
55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36969244 |
56 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.30520002 |
57 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27022937 |
58 | MAF_26560356_Chip-Seq_TH2_Human | 1.24740043 |
59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21406542 |
60 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.21231061 |
61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19180965 |
62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15964207 |
63 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15033339 |
64 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.11665557 |
65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08756686 |
66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06947564 |
67 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05643248 |
68 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02161565 |
69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01960272 |
70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01338640 |
71 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.99722117 |
72 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.98722100 |
73 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93735125 |
74 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.93000150 |
75 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92959396 |
76 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92663834 |
77 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.92591074 |
78 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91904227 |
79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90251203 |
80 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.88913758 |
81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87489081 |
82 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.86374491 |
83 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.86176826 |
84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85506848 |
85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.84795434 |
86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83835779 |
87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83562289 |
88 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83546498 |
89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83069565 |
90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82899784 |
91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82636924 |
92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82195298 |
93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80586362 |
94 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79980168 |
95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79766622 |
96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79677608 |
97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79669107 |
98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79659611 |
99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78921382 |
100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78875672 |
101 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.77999696 |
102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77864199 |
103 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77355866 |
104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77073530 |
105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76761318 |
106 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.76564849 |
107 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.74820995 |
108 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.74674054 |
109 | KDM2B_26808549_Chip-Seq_K562_Human | 0.73823716 |
110 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73568194 |
111 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.73531030 |
112 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73279476 |
113 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.71458280 |
114 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70682931 |
115 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.67612890 |
116 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.67589591 |
117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.66963988 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 3.44344293 |
2 | MP0001835_abnormal_antigen_presentation | 3.28966764 |
3 | MP0002166_altered_tumor_susceptibility | 3.19016508 |
4 | MP0003763_abnormal_thymus_physiology | 3.17300794 |
5 | MP0009278_abnormal_bone_marrow | 3.00530600 |
6 | MP0005671_abnormal_response_to | 2.84692537 |
7 | MP0003303_peritoneal_inflammation | 2.65261136 |
8 | MP0001800_abnormal_humoral_immune | 2.62034256 |
9 | MP0003300_gastrointestinal_ulcer | 2.61292973 |
10 | MP0002006_tumorigenesis | 2.55150451 |
11 | * MP0000703_abnormal_thymus_morphology | 2.51969607 |
12 | MP0000685_abnormal_immune_system | 2.47252516 |
13 | MP0005000_abnormal_immune_tolerance | 2.40212614 |
14 | MP0008260_abnormal_autophagy | 2.38930718 |
15 | * MP0002398_abnormal_bone_marrow | 2.38326596 |
16 | * MP0005387_immune_system_phenotype | 2.30247077 |
17 | * MP0001790_abnormal_immune_system | 2.30247077 |
18 | MP0002452_abnormal_antigen_presenting | 2.27807478 |
19 | MP0002420_abnormal_adaptive_immunity | 2.25589838 |
20 | MP0001819_abnormal_immune_cell | 2.23120708 |
21 | * MP0002723_abnormal_immune_serum | 2.18685326 |
22 | MP0006082_CNS_inflammation | 2.09780846 |
23 | * MP0004808_abnormal_hematopoietic_stem | 2.09142387 |
24 | MP0003436_decreased_susceptibility_to | 2.08934083 |
25 | MP0005076_abnormal_cell_differentiation | 2.06759702 |
26 | * MP0000716_abnormal_immune_system | 2.04934068 |
27 | MP0002396_abnormal_hematopoietic_system | 2.00411040 |
28 | MP0002419_abnormal_innate_immunity | 1.99235300 |
29 | * MP0004947_skin_inflammation | 1.98003748 |
30 | MP0009785_altered_susceptibility_to | 1.95612373 |
31 | * MP0002722_abnormal_immune_system | 1.95564901 |
32 | MP0010155_abnormal_intestine_physiology | 1.93430777 |
33 | MP0005025_abnormal_response_to | 1.92587714 |
34 | * MP0002405_respiratory_system_inflammati | 1.88372141 |
35 | MP0003705_abnormal_hypodermis_morpholog | 1.85182767 |
36 | * MP0000689_abnormal_spleen_morphology | 1.84174142 |
37 | MP0005397_hematopoietic_system_phenotyp | 1.77361994 |
38 | MP0001545_abnormal_hematopoietic_system | 1.77361994 |
39 | MP0010094_abnormal_chromosome_stability | 1.76015172 |
40 | MP0009333_abnormal_splenocyte_physiolog | 1.68334429 |
41 | MP0010307_abnormal_tumor_latency | 1.64150342 |
42 | * MP0002429_abnormal_blood_cell | 1.63594573 |
43 | MP0002148_abnormal_hypersensitivity_rea | 1.63430216 |
44 | MP0005464_abnormal_platelet_physiology | 1.63302108 |
45 | MP0010352_gastrointestinal_tract_polyps | 1.60885061 |
46 | MP0005451_abnormal_body_composition | 1.59259307 |
47 | MP0002132_abnormal_respiratory_system | 1.58136958 |
48 | MP0003172_abnormal_lysosome_physiology | 1.57512870 |
49 | MP0008961_abnormal_basal_metabolism | 1.53739563 |
50 | MP0001849_ear_inflammation | 1.48454675 |
51 | MP0002877_abnormal_melanocyte_morpholog | 1.46304071 |
52 | MP0004510_myositis | 1.40258393 |
53 | MP0002933_joint_inflammation | 1.38434476 |
54 | MP0000465_gastrointestinal_hemorrhage | 1.36301228 |
55 | MP0001873_stomach_inflammation | 1.33597539 |
56 | MP0005310_abnormal_salivary_gland | 1.32319637 |
57 | * MP0001845_abnormal_inflammatory_respons | 1.29182810 |
58 | MP0003448_altered_tumor_morphology | 1.29114532 |
59 | MP0008877_abnormal_DNA_methylation | 1.28616280 |
60 | MP0003183_abnormal_peptide_metabolism | 1.25289125 |
61 | MP0003191_abnormal_cellular_cholesterol | 1.23546162 |
62 | MP0004185_abnormal_adipocyte_glucose | 1.21761402 |
63 | MP0008057_abnormal_DNA_replication | 1.20366697 |
64 | MP0001851_eye_inflammation | 1.16301530 |
65 | MP0004883_abnormal_blood_vessel | 1.13466287 |
66 | MP0002009_preneoplasia | 1.12901272 |
67 | MP0000490_abnormal_crypts_of | 1.12308920 |
68 | MP0003866_abnormal_defecation | 1.12113770 |
69 | MP0002998_abnormal_bone_remodeling | 1.09042733 |
70 | MP0003045_fibrosis | 1.07732917 |
71 | MP0000383_abnormal_hair_follicle | 1.07426218 |
72 | MP0005621_abnormal_cell_physiology | 1.07071001 |
73 | MP0003221_abnormal_cardiomyocyte_apopto | 1.06274712 |
74 | MP0001730_embryonic_growth_arrest | 1.05970391 |
75 | MP0001853_heart_inflammation | 1.05855872 |
76 | * MP0005174_abnormal_tail_pigmentation | 1.04687532 |
77 | MP0000858_altered_metastatic_potential | 1.01483464 |
78 | MP0001533_abnormal_skeleton_physiology | 0.97087924 |
79 | MP0003111_abnormal_nucleus_morphology | 0.96965387 |
80 | MP0005058_abnormal_lysosome_morphology | 0.95607630 |
81 | MP0003453_abnormal_keratinocyte_physiol | 0.94361214 |
82 | MP0003724_increased_susceptibility_to | 0.93982721 |
83 | MP0001672_abnormal_embryogenesis/_devel | 0.93004433 |
84 | MP0005380_embryogenesis_phenotype | 0.93004433 |
85 | * MP0002095_abnormal_skin_pigmentation | 0.90875954 |
86 | MP0003787_abnormal_imprinting | 0.87348394 |
87 | MP0003656_abnormal_erythrocyte_physiolo | 0.86761789 |
88 | MP0003828_pulmonary_edema | 0.85866678 |
89 | MP0004957_abnormal_blastocyst_morpholog | 0.85830650 |
90 | MP0002019_abnormal_tumor_incidence | 0.85193044 |
91 | MP0010678_abnormal_skin_adnexa | 0.81404556 |
92 | MP0001879_abnormal_lymphatic_vessel | 0.81192922 |
93 | MP0004264_abnormal_extraembryonic_tissu | 0.80928389 |
94 | MP0000767_abnormal_smooth_muscle | 0.79995639 |
95 | MP0003077_abnormal_cell_cycle | 0.78210854 |
96 | MP0009672_abnormal_birth_weight | 0.76100863 |
97 | MP0003690_abnormal_glial_cell | 0.75602963 |
98 | MP0001697_abnormal_embryo_size | 0.75256334 |
99 | MP0004197_abnormal_fetal_growth/weight/ | 0.75150565 |
100 | MP0002133_abnormal_respiratory_system | 0.73566379 |
101 | MP0005388_respiratory_system_phenotype | 0.73566379 |
102 | MP0000350_abnormal_cell_proliferation | 0.71912879 |
103 | MP0001216_abnormal_epidermal_layer | 0.70746967 |
104 | MP0000733_abnormal_muscle_development | 0.70484569 |
105 | MP0001191_abnormal_skin_condition | 0.70389398 |
106 | MP0005164_abnormal_response_to | 0.69899146 |
107 | MP0003091_abnormal_cell_migration | 0.68546640 |
108 | MP0000371_diluted_coat_color | 0.66224822 |
109 | MP0003566_abnormal_cell_adhesion | 0.65963832 |
110 | MP0000920_abnormal_myelination | 0.64622895 |
111 | * MP0002075_abnormal_coat/hair_pigmentati | 0.64573132 |
112 | MP0001915_intracranial_hemorrhage | 0.61978134 |
113 | MP0002925_abnormal_cardiovascular_devel | 0.61642334 |
114 | MP0004381_abnormal_hair_follicle | 0.61621611 |
115 | MP0005075_abnormal_melanosome_morpholog | 0.60309129 |
116 | * MP0000015_abnormal_ear_pigmentation | 0.60283457 |
117 | MP0008007_abnormal_cellular_replicative | 0.59266405 |
118 | MP0008770_decreased_survivor_rate | 0.57908484 |
119 | MP0000313_abnormal_cell_death | 0.57077589 |
120 | MP0002086_abnormal_extraembryonic_tissu | 0.56976352 |
121 | MP0008469_abnormal_protein_level | 0.56164303 |
122 | MP0002088_abnormal_embryonic_growth/wei | 0.54479419 |
123 | MP0003984_embryonic_growth_retardation | 0.53987587 |
124 | MP0001784_abnormal_fluid_regulation | 0.49971012 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 5.92029969 |
2 | Abnormality of T cell number (HP:0011839) | 5.59925784 |
3 | Abnormality of B cell number (HP:0010975) | 5.44683117 |
4 | B lymphocytopenia (HP:0010976) | 5.44683117 |
5 | Thyroiditis (HP:0100646) | 5.19762606 |
6 | Panhypogammaglobulinemia (HP:0003139) | 5.11656129 |
7 | Recurrent viral infections (HP:0004429) | 4.96461036 |
8 | Severe combined immunodeficiency (HP:0004430) | 4.65970320 |
9 | Eosinophilia (HP:0001880) | 4.39796680 |
10 | Hypoplasia of the thymus (HP:0000778) | 4.27990863 |
11 | Recurrent fungal infections (HP:0002841) | 4.22738961 |
12 | Combined immunodeficiency (HP:0005387) | 4.00097805 |
13 | Abnormality of the fingertips (HP:0001211) | 3.58464751 |
14 | Eczematoid dermatitis (HP:0000976) | 3.56332105 |
15 | Granulocytopenia (HP:0001913) | 3.48370387 |
16 | Hyperacusis (HP:0010780) | 3.40280904 |
17 | Recurrent abscess formation (HP:0002722) | 3.38904012 |
18 | Abnormality of eosinophils (HP:0001879) | 3.36481171 |
19 | Abnormality of T cells (HP:0002843) | 3.29831829 |
20 | Recurrent bacterial skin infections (HP:0005406) | 3.05384097 |
21 | Hypoproteinemia (HP:0003075) | 2.97777329 |
22 | Leukocytosis (HP:0001974) | 2.89091210 |
23 | Chronic otitis media (HP:0000389) | 2.82923688 |
24 | Subacute progressive viral hepatitis (HP:0006572) | 2.75179533 |
25 | Autoimmune thrombocytopenia (HP:0001973) | 2.73500792 |
26 | Meningitis (HP:0001287) | 2.70072591 |
27 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.65878981 |
28 | Abnormal platelet volume (HP:0011876) | 2.61192323 |
29 | Prolonged bleeding time (HP:0003010) | 2.56360773 |
30 | Viral hepatitis (HP:0006562) | 2.52187148 |
31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.50333540 |
32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.50333540 |
33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46267564 |
34 | Gastrointestinal infarctions (HP:0005244) | 2.44623254 |
35 | IgG deficiency (HP:0004315) | 2.44324734 |
36 | Mediastinal lymphadenopathy (HP:0100721) | 2.43111730 |
37 | Nasal polyposis (HP:0100582) | 2.42622307 |
38 | Keratoconjunctivitis sicca (HP:0001097) | 2.39616071 |
39 | Elfin facies (HP:0004428) | 2.38042843 |
40 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.37050334 |
41 | Volvulus (HP:0002580) | 2.34025223 |
42 | Obstructive lung disease (HP:0006536) | 2.31693451 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31693451 |
44 | Myositis (HP:0100614) | 2.31240591 |
45 | Bladder carcinoma (HP:0002862) | 2.26820618 |
46 | Bladder neoplasm (HP:0009725) | 2.26820618 |
47 | Encephalitis (HP:0002383) | 2.25768022 |
48 | Disinhibition (HP:0000734) | 2.23782631 |
49 | Uterine leiomyosarcoma (HP:0002891) | 2.23263641 |
50 | Leiomyosarcoma (HP:0100243) | 2.23263641 |
51 | Slow saccadic eye movements (HP:0000514) | 2.21158383 |
52 | Inflammation of the large intestine (HP:0002037) | 2.19881761 |
53 | Overriding aorta (HP:0002623) | 2.19112768 |
54 | Amaurosis fugax (HP:0100576) | 2.19091788 |
55 | Recurrent skin infections (HP:0001581) | 2.18507887 |
56 | Cellulitis (HP:0100658) | 2.18486761 |
57 | Increased nuchal translucency (HP:0010880) | 2.18284750 |
58 | Papillary thyroid carcinoma (HP:0002895) | 2.16600313 |
59 | Increased mean platelet volume (HP:0011877) | 2.16164152 |
60 | Gingival bleeding (HP:0000225) | 2.15844270 |
61 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.15825796 |
62 | Epistaxis (HP:0000421) | 2.15672840 |
63 | Heterotopia (HP:0002282) | 2.14442627 |
64 | Absent frontal sinuses (HP:0002688) | 2.13199372 |
65 | Keratoconjunctivitis (HP:0001096) | 2.11775698 |
66 | Gastrointestinal inflammation (HP:0004386) | 2.09476741 |
67 | Upper motor neuron abnormality (HP:0002127) | 2.09292550 |
68 | Stomatitis (HP:0010280) | 2.08465610 |
69 | Macroorchidism (HP:0000053) | 2.08069892 |
70 | Renovascular hypertension (HP:0100817) | 2.08012920 |
71 | Periodontitis (HP:0000704) | 2.06979399 |
72 | Erythroderma (HP:0001019) | 2.06846378 |
73 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.06070804 |
74 | Gastrointestinal carcinoma (HP:0002672) | 2.06070804 |
75 | Vertebral arch anomaly (HP:0008438) | 2.05807545 |
76 | Long eyelashes (HP:0000527) | 2.03916793 |
77 | Urticaria (HP:0001025) | 2.03173548 |
78 | Metaphyseal cupping (HP:0003021) | 2.02673565 |
79 | Pustule (HP:0200039) | 2.02060116 |
80 | Gingivitis (HP:0000230) | 2.01838485 |
81 | Spontaneous hematomas (HP:0007420) | 2.00526947 |
82 | Recurrent bronchitis (HP:0002837) | 1.98034698 |
83 | IgM deficiency (HP:0002850) | 1.95773777 |
84 | Basal cell carcinoma (HP:0002671) | 1.93547276 |
85 | Colitis (HP:0002583) | 1.92651560 |
86 | Abnormality of the nasal mucosa (HP:0000433) | 1.92599821 |
87 | Peritonitis (HP:0002586) | 1.92060850 |
88 | Sepsis (HP:0100806) | 1.90654875 |
89 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.90560424 |
90 | Optic neuritis (HP:0100653) | 1.89006613 |
91 | Retrobulbar optic neuritis (HP:0100654) | 1.89006613 |
92 | Acute myeloid leukemia (HP:0004808) | 1.87919188 |
93 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.84298371 |
94 | Flat cornea (HP:0007720) | 1.83838045 |
95 | Hematochezia (HP:0002573) | 1.83370413 |
96 | Orchitis (HP:0100796) | 1.81542538 |
97 | Increased IgE level (HP:0003212) | 1.81387012 |
98 | Abnormality of macrophages (HP:0004311) | 1.80840676 |
99 | Lymphoma (HP:0002665) | 1.79768773 |
100 | Hemoptysis (HP:0002105) | 1.79592054 |
101 | Ankyloglossia (HP:0010296) | 1.79591305 |
102 | Abnormality of the columella (HP:0009929) | 1.78175603 |
103 | Ectopic kidney (HP:0000086) | 1.77218542 |
104 | Renal cell carcinoma (HP:0005584) | 1.76943872 |
105 | Cutis marmorata (HP:0000965) | 1.76873663 |
106 | Abnormality of the peritoneum (HP:0002585) | 1.76562415 |
107 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.76399650 |
108 | Broad face (HP:0000283) | 1.75819322 |
109 | Acute lymphatic leukemia (HP:0006721) | 1.75188662 |
110 | Vasculitis (HP:0002633) | 1.74484423 |
111 | Conjunctival telangiectasia (HP:0000524) | 1.74228962 |
112 | Prominent nose (HP:0000448) | 1.74148802 |
113 | Abnormality of oral frenula (HP:0000190) | 1.72960034 |
114 | Obsessive-compulsive behavior (HP:0000722) | 1.72070220 |
115 | Verrucae (HP:0200043) | 1.71951959 |
116 | Papilloma (HP:0012740) | 1.71951959 |
117 | Agammaglobulinemia (HP:0004432) | 1.70884190 |
118 | Renal duplication (HP:0000075) | 1.70666938 |
119 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69958543 |
120 | Dislocated radial head (HP:0003083) | 1.68247439 |
121 | Lymphopenia (HP:0001888) | 1.67474117 |
122 | Inappropriate behavior (HP:0000719) | 1.66862858 |
123 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.66406969 |
124 | Narrow palate (HP:0000189) | 1.64893684 |
125 | Arterial thrombosis (HP:0004420) | 1.64492355 |
126 | Low anterior hairline (HP:0000294) | 1.64313680 |
127 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.64042662 |
128 | Spondylolisthesis (HP:0003302) | 1.63424498 |
129 | Abnormality of the thymus (HP:0000777) | 1.62773849 |
130 | Pulmonary infiltrates (HP:0002113) | 1.61085112 |
131 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.60852701 |
132 | Bronchiectasis (HP:0002110) | 1.60599687 |
133 | Chest pain (HP:0100749) | 1.60526764 |
134 | Ureteral obstruction (HP:0006000) | 1.60287818 |
135 | Short 4th metacarpal (HP:0010044) | 1.60257172 |
136 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.60257172 |
137 | Osteomyelitis (HP:0002754) | 1.59787145 |
138 | Insomnia (HP:0100785) | 1.59439536 |
139 | Fatigue (HP:0012378) | 1.59000999 |
140 | Amyotrophic lateral sclerosis (HP:0007354) | 1.58665459 |
141 | Chronic sinusitis (HP:0011109) | 1.58080053 |
142 | Ureteral stenosis (HP:0000071) | 1.58006902 |
143 | Syringomyelia (HP:0003396) | 1.57499084 |
144 | Spinal cord lesions (HP:0100561) | 1.57499084 |
145 | Pulmonary embolism (HP:0002204) | 1.54256287 |
146 | Long palpebral fissure (HP:0000637) | 1.54151311 |
147 | Cortical dysplasia (HP:0002539) | 1.53950099 |
148 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.53604152 |
149 | Skin ulcer (HP:0200042) | 1.51810614 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.25130650 |
2 | TXK | 4.19672031 |
3 | CDK12 | 3.45726129 |
4 | PRPF4B | 2.88015270 |
5 | SIK2 | 2.66459888 |
6 | ZAP70 | 2.44592500 |
7 | MAP3K10 | 2.29781879 |
8 | STK10 | 2.12304399 |
9 | RIPK4 | 2.10814694 |
10 | TYK2 | 2.10260646 |
11 | FGR | 2.09835352 |
12 | ITK | 2.05024283 |
13 | FGFR3 | 1.90263494 |
14 | EEF2K | 1.89166899 |
15 | CAMK1G | 1.87416378 |
16 | CLK1 | 1.86021392 |
17 | BRD4 | 1.80421458 |
18 | CAMK1D | 1.77277816 |
19 | PNCK | 1.70289571 |
20 | SMG1 | 1.69128477 |
21 | KSR2 | 1.62978890 |
22 | JAK3 | 1.61447002 |
23 | * HCK | 1.60581824 |
24 | GRK6 | 1.60305116 |
25 | BTK | 1.57474609 |
26 | WNK1 | 1.54698056 |
27 | EPHB1 | 1.50871583 |
28 | * SYK | 1.48289239 |
29 | CSK | 1.43805216 |
30 | CDK6 | 1.43510710 |
31 | JAK1 | 1.41387394 |
32 | * LCK | 1.34900906 |
33 | IRAK4 | 1.34215970 |
34 | NEK2 | 1.31194648 |
35 | TAF1 | 1.27816460 |
36 | CSF1R | 1.27495656 |
37 | FGFR2 | 1.21352229 |
38 | NEK9 | 1.16894420 |
39 | MAPK7 | 1.15355614 |
40 | MAP3K14 | 1.13491528 |
41 | FES | 1.12221416 |
42 | DMPK | 1.08969259 |
43 | IRAK2 | 1.06810167 |
44 | STK4 | 1.05642545 |
45 | IRAK1 | 1.05558602 |
46 | STK24 | 1.04614175 |
47 | TEC | 1.03238022 |
48 | PKN2 | 1.02819149 |
49 | ALK | 1.02400350 |
50 | MAP3K7 | 1.02263105 |
51 | PTK6 | 1.01986953 |
52 | KSR1 | 1.01312982 |
53 | MARK2 | 1.00454179 |
54 | STK3 | 0.99576166 |
55 | CDK19 | 0.99445999 |
56 | TGFBR2 | 0.96327695 |
57 | CDK9 | 0.95952851 |
58 | FGFR4 | 0.95825963 |
59 | PRKCQ | 0.93396561 |
60 | SGK3 | 0.92526903 |
61 | CDK4 | 0.91457685 |
62 | * PDGFRB | 0.89050678 |
63 | BMX | 0.84468706 |
64 | PTK2B | 0.84168912 |
65 | BLK | 0.83886986 |
66 | * YES1 | 0.83676633 |
67 | KIT | 0.83254059 |
68 | TRIB3 | 0.83207805 |
69 | TAOK1 | 0.83079470 |
70 | CDC7 | 0.83017356 |
71 | PRKCH | 0.82116880 |
72 | HIPK2 | 0.81175590 |
73 | TAOK3 | 0.80965961 |
74 | IKBKE | 0.80895866 |
75 | JAK2 | 0.80599879 |
76 | LYN | 0.80521917 |
77 | MARK3 | 0.80310810 |
78 | PIM1 | 0.79705215 |
79 | LRRK2 | 0.79308107 |
80 | MAP3K13 | 0.76653268 |
81 | NLK | 0.71984857 |
82 | RPS6KA4 | 0.71404490 |
83 | MAP2K3 | 0.71234342 |
84 | CSNK1A1L | 0.70884746 |
85 | ATR | 0.69553585 |
86 | MAP3K8 | 0.69150606 |
87 | PASK | 0.69011472 |
88 | MAP3K3 | 0.68360843 |
89 | LATS1 | 0.67919031 |
90 | MAP3K1 | 0.67528483 |
91 | MTOR | 0.67347513 |
92 | RAF1 | 0.63738888 |
93 | TNK2 | 0.63652313 |
94 | CHUK | 0.63533187 |
95 | CDK3 | 0.62740706 |
96 | MAP3K6 | 0.61586077 |
97 | TBK1 | 0.60986080 |
98 | MELK | 0.60814465 |
99 | DYRK3 | 0.60444927 |
100 | PIK3CG | 0.60362763 |
101 | CAMKK1 | 0.60107065 |
102 | IKBKB | 0.59850843 |
103 | ERN1 | 0.59215672 |
104 | CAMK4 | 0.58939771 |
105 | MST4 | 0.57743613 |
106 | CAMKK2 | 0.57078756 |
107 | CHEK1 | 0.56399863 |
108 | PDK1 | 0.53577251 |
109 | MATK | 0.52462700 |
110 | MAPK12 | 0.51201906 |
111 | TRPM7 | 0.51105800 |
112 | STK11 | 0.50922956 |
113 | RPS6KL1 | 0.50735542 |
114 | RPS6KC1 | 0.50735542 |
115 | TYRO3 | 0.50695809 |
116 | TTN | 0.50589240 |
117 | RET | 0.50301041 |
118 | * FYN | 0.50069932 |
119 | PDGFRA | 0.47963601 |
120 | MAP3K9 | 0.47267185 |
121 | MAPK4 | 0.46778085 |
122 | SGK223 | 0.46485507 |
123 | SGK494 | 0.46485507 |
124 | * EGFR | 0.46461192 |
125 | CDC42BPA | 0.45936768 |
126 | * ABL1 | 0.45548138 |
127 | SIK3 | 0.45463385 |
128 | RIPK1 | 0.45042119 |
129 | ATM | 0.44910376 |
130 | NTRK2 | 0.44074006 |
131 | MAP3K2 | 0.43846484 |
132 | RPS6KA6 | 0.38510030 |
133 | MAPKAPK2 | 0.38508760 |
134 | SGK2 | 0.37140379 |
135 | NUAK1 | 0.37039594 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.67455525 |
2 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.34150086 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.05209424 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02946531 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90392654 |
6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.86599573 |
7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80908316 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75661745 |
9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73676751 |
10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67408014 |
11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60888472 |
12 | Measles_Homo sapiens_hsa05162 | 1.58191637 |
13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58080943 |
14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50511697 |
15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46876975 |
16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.44131143 |
17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.41765475 |
18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35693082 |
19 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.35415347 |
20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32913214 |
21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30594532 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30510565 |
23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.30257397 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23208455 |
25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18878578 |
26 | Hepatitis B_Homo sapiens_hsa05161 | 1.17970529 |
27 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17506068 |
28 | Colorectal cancer_Homo sapiens_hsa05210 | 1.17494078 |
29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17430360 |
30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15992837 |
31 | Tuberculosis_Homo sapiens_hsa05152 | 1.12978560 |
32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12639209 |
33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10161093 |
34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.07433156 |
35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07317992 |
36 | Influenza A_Homo sapiens_hsa05164 | 1.05309651 |
37 | Platelet activation_Homo sapiens_hsa04611 | 1.04831384 |
38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00190813 |
39 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.99458279 |
40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99308372 |
41 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99001136 |
42 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99000592 |
43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96841273 |
44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95991345 |
45 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95856562 |
46 | Shigellosis_Homo sapiens_hsa05131 | 0.95156835 |
47 | Pertussis_Homo sapiens_hsa05133 | 0.94377375 |
48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93810601 |
49 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90906908 |
50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90480409 |
51 | Adherens junction_Homo sapiens_hsa04520 | 0.89751844 |
52 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87869355 |
53 | Apoptosis_Homo sapiens_hsa04210 | 0.87813628 |
54 | Salmonella infection_Homo sapiens_hsa05132 | 0.86616925 |
55 | Lysine degradation_Homo sapiens_hsa00310 | 0.84821493 |
56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84232356 |
57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83874446 |
58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83041081 |
59 | Prostate cancer_Homo sapiens_hsa05215 | 0.82931972 |
60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82619264 |
61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81488372 |
62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80992286 |
63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80515530 |
64 | Allograft rejection_Homo sapiens_hsa05330 | 0.79364884 |
65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77442157 |
66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76397429 |
67 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75748177 |
68 | Glioma_Homo sapiens_hsa05214 | 0.74527789 |
69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74253567 |
70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73857892 |
71 | Amoebiasis_Homo sapiens_hsa05146 | 0.73411274 |
72 | Phagosome_Homo sapiens_hsa04145 | 0.73256817 |
73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71390450 |
74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70942934 |
75 | Legionellosis_Homo sapiens_hsa05134 | 0.69534151 |
76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69463067 |
77 | Focal adhesion_Homo sapiens_hsa04510 | 0.69057782 |
78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68558208 |
79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68466974 |
80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68145001 |
81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67675027 |
82 | Malaria_Homo sapiens_hsa05144 | 0.66996692 |
83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66688952 |
84 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.66592974 |
85 | Bladder cancer_Homo sapiens_hsa05219 | 0.66534697 |
86 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65917966 |
87 | * Endocytosis_Homo sapiens_hsa04144 | 0.65869075 |
88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65598166 |
89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65241034 |
90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63792142 |
91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63626194 |
92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63231635 |
93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62317067 |
94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61746826 |
95 | Hepatitis C_Homo sapiens_hsa05160 | 0.61651124 |
96 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60539897 |
97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60065757 |
98 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60057179 |
99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58541630 |
100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58252872 |
101 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56372821 |
102 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.56034894 |
103 | Lysosome_Homo sapiens_hsa04142 | 0.55025854 |
104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54570335 |
105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53846054 |
106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.53258250 |
107 | Cell cycle_Homo sapiens_hsa04110 | 0.53244016 |
108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52402299 |
109 | Asthma_Homo sapiens_hsa05310 | 0.51719301 |
110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51384230 |
111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51110033 |
112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51079508 |
113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51033879 |
114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50464973 |
115 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50037446 |
116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49954657 |